TV drug ad spending continued downward slope in May, with AbbVie’s Skyrizi hanging on to top spot
After a strong start to the year—as evidenced by the nearly 30% year-over-year increase in the top 10 brands’ first-quarter TV drug ad outlay—spending on pharmaceutical commercials has slowed throughout the second quarter so far.
After a strong start to the year—as evidenced by the nearly 30% year-over-year increase in the top 10 brands’ first-quarter TV drug ad outlay—spending on pharmaceutical commercials has slowed throughout the second quarter so far.
